Explore more than 1.3 million company profiles from emerging markets

Inti (Bolivia)

Principales Actividades: Manufactura de Medicinas y Productos Farmacéuticos
Estados Financieros
Estadísticas Principales
Seleccionar elementos para visualizarlos como gráfico. 2014 Y
Ingresos netos por ventas
Total Ingreso Operativo
Ganancia operativa (EBIT)
EBITDA
Ganancia (Pérdida) Neta
Activos Totales 462,803
Total de patrimonio
Margen de ganancias operativas
Rendimiento sobre ventas
Rendimiento sobre el Capital
Deuda sobre capital
Prueba del Ácido
Coeficiente de efectivo
Nota: Unidades en Miles. Estado Financiero: No Auditado, Individual
Fuente: Autoridad de Supervision del Sistema Financiero (ASFI), Base de Datos de Compañía de EMIS.
Descripción de Compañías

Drogueria Inti S.A. es una compañía que opera en la industria farmacéutica de Bolivia. Actualmente es la mas grande e importante en este sector. Bajo la misión de proteger y preservar la salud de las personas fabrican distintos tipos de medicamentos. Posee un certificado de buenas practicas de manufactura otorgado por el Ministerio de Salud y Deportes de Bolivia.

Más
Productos Principales

Medicamentos

Información de Contacto

Casa Matriz
C./ Lucas Jaimes Nº 1959
La Paz; La Paz;
Código Postal: 1421
Teléfono: +591-2-217-6600
Fax: +591-2-22-1987
Correo Electrónico: drogueria@inti.com.bo
Página Web: http://www.inti.com.bo

Nombre Completo: Droguería Inti S.A.

Estado: No Inscritas
Forma Legal: Sociedad Anónima
Estatus Operacional: Operacional
NIT: 1020521023
Fecha de Incorporación: 1936

Información básica
Total de Empleados:
()
Principales Ejecutivos
Presidente del Directorio
Más
Detalles de Accionistas
Schilling Dalgas Christian
26,45%
Más
Eventos Corporativos
Transacciones EMIS DealWatch
Intentos de Transacciones DealMonitor
Noticias EMIS DealWatch
Doc. Financieros - Reportes Anuales
Competidores - Bolivia
BOB | USD | EUR
Análisis/Investigación

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

USE OF YOUR INFORMATION:
EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.